NDC 50419-310-01 - Vasovist

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
50419-310
Requested NDC
50419-310-01
Package NDCs from labels
50419-310-01, 50419-310-02
Manufacturer
Bayer Healthcare, Inc.
Effective date
2009-01-02
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Vasovist - Bayer Healthcare, Inc.Bayer Healthcare, Inc.2009-01-02HUMAN PRESCRIPTION DRUG LABEL WITH HIGHLIGHTS

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50419-310-01Vasovist10 mL in 1 VIAL, GLASSINJECTION101
50419-310-01Vasovist10 in 1 CARTONINJECTION101
50419-310-02Vasovist15 mL in 1 VIAL, GLASSINJECTION151
50419-310-02Vasovist10 in 1 CARTONINJECTION101

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50419-310VASOVIST (GADOFOSVESET TRISODIUM) INJECTION [BAYER HEALTHCARE, INC.]14 package rows20090109_B6C35A62-A7EA-4C1D-A00A-24D82CDC65BE.zip

DailyMed Socrata Ingredients#

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
4005F92E-1AC6-1CE7-EDA0-1A3FDF04CB7EB6C35A62-A7EA-4C1D-A00A-24D82CDC65BE2009-01-02Boxed warning, Warnings, Adverse reactionsExact identifier
spl id: 4005F92E-1AC6-1CE7-EDA0-1A3FDF04CB7E
spl set id: B6C35A62-A7EA-4C1D-A00A-24D82CDC65BE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.